INTRODUCTION
============

The importance of life-course perspective in dementia prevention has been acknowledged \[[@b1-jpmph-49-2-134]\] and according to the Barker's hypothesis, or the developmental origins of health and disease (DOHAD), the susceptibility to many chronic diseases is determined already *in utero* \[[@b2-jpmph-49-2-134]\]. However, studies on the prenatal exposures and dementia face many practical challenges and are, to date, non-existent. Month or season of birth has been implied as an exogenous indicator of early life environment, i.e., a variable that is independent of individual circumstances at the time of birth and during the life course \[[@b3-jpmph-49-2-134]\].

Season of birth has been suggested to increase the risk of adverse psychiatric \[[@b4-jpmph-49-2-134]\] and neurological \[[@b5-jpmph-49-2-134]\] outcomes. The findings have been most consistent for schizophrenia, with winter births being linked to higher risk of schizophrenia \[[@b4-jpmph-49-2-134],[@b6-jpmph-49-2-134]\] and associated ventricular changes \[[@b7-jpmph-49-2-134]\]. On the other hand, it has been suggested that the seasonal variation in schizophrenia has decreased, with evident seasonal association among those born in 1950s but no longer in those born in 1960s \[[@b8-jpmph-49-2-134]\]. Studies on Alzheimer's disease (AD) and dementia have been less consistent, with some studies reporting an excess of births in the first quarter of the year \[[@b9-jpmph-49-2-134]\] or deficit of spring births \[[@b10-jpmph-49-2-134]\] among AD cases and deficit of winter births among dementia cases \[[@b3-jpmph-49-2-134]\]. Other studies have been unable to replicate this association \[[@b11-jpmph-49-2-134]-[@b16-jpmph-49-2-134]\]. This may be due to lack of power due to small sample size.

We investigated the association between month and season of birth in a nationwide nested case-control study (1:4, n=353 581) including all community-dwelling persons in Finland who received a clinically verified AD diagnosis in 2005 to 2011 (n=70 719).

METHODS
=======

Study Population
----------------

The Medication and Alzheimer's Disease cohort includes all community-dwelling persons of Finland, who received a clinically verified diagnosis of AD in 2005 to 2011 (n=70 719: AD cases of the present study). The age range was 34 to 105 years (mean, 80.1; standard deviation, 7.1 years) and 46 117 (65.2%) were females. In order to conduct a nested case-control study of the entire population of Finland, one to four age- matched (+/- one year), sex- matched and region of residence-matched controls were identified from the register that contains all residents of Finland who are entitled to benefits by the Social Insurance Institution (SII), i.e., all citizens and residents living in Finland for at least two years. The final study size was 353 581 (70 719 cases and 282 862 controls).

Each resident of Finland is assigned a unique personal identification code which was used link the participant data. All data were de-identified before submission to the research team and ethics committee approval or informed consent were not required as only de-identified data were used and the study participants were not contacted.

Diagnosis of Alzheimer's Disease
--------------------------------

AD cases were identified from the Finnish Special Reimbursement Register maintained by the SII of Finland as described in detail previously \[[@b17-jpmph-49-2-134]\]. The Special Reimbursement Register contains records of all persons who are eligible for higher reimbursement due to certain chronic diseases, including AD. To be eligible for reimbursement, the disease must be diagnosed according to specific criterion and diagnosis statement must be submitted to the SII by a physician.

Briefly, the specific criterion for a clinically verified AD diagnosis are 1) symptoms consistent with mild or moderate AD, 2) a decrease in social capacity over a period of at least 3 months, 3) a computer tomography/magnetic resonance imaging scan, 4) exclusion of possible alternative diagnoses, and 5) confirmation of the diagnosis by a registered neurologist or geriatrician. The AD diagnosis was based on the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association) and Diagnostic and Statistical Manual of Mental Disorders, 4th edition criteria for Alzheimer's diseases \[[@b18-jpmph-49-2-134],[@b19-jpmph-49-2-134]\].

Exposures
---------

Birth months were categorised to summer (June-August), autumn (September-October), winter (November-February) and spring (March-May).

Statistical Analyses
--------------------

Statistical analyses were conducted with Stata version 12.0 (StataCorp, College Station, TX, USA). The association of exposures and AD were assessed with conditional logistic regression that accounted for matching. The *p*-values in [Tables 1](#t1-jpmph-49-2-134){ref-type="table"} and [2](#t2-jpmph-49-2-134){ref-type="table"} represent the overall association between month or season of birth and AD (i.e., the *p*-value from conditional logistic regression model with AD as an outcome and month or season of birth as an exposure).

RESULTS
=======

Birth months of the AD cases and controls are shown in [Table 1](#t1-jpmph-49-2-134){ref-type="table"}. Month of birth was not associated with AD. There was some suggestion that AD cases were more commonly born in July than controls (odds ratio, 1.04; 95% confidence interval \[CI\], 1.00 to 1.08) but the absolute difference was only 0.3%. Similarly, no association was observed between season of birth and AD ([Table 2](#t2-jpmph-49-2-134){ref-type="table"}), although there was some suggestion for winter births being less common, and summer births being more common among AD cases than in controls. However, the absolute differences were only 0.5% for winter births and 0.3% for summer births, respectively and the 95% CIs included 1.

DISCUSSION
==========

We found no strong evidence that month or season of birth is related to risk of AD in our nationwide case-control study. There was some suggestion for lower prevalence of winter births among AD cases, but the absolute difference in those born during winter months between the cases and controls was very small. Thus, the results should be interpreted as null. Further, an adjustment for multiple comparison would render the *p*-values even further away from the conventional thresh-old of statistical significance.

Even though the inverse association between winter birth and AD was modest, our findings are in line with recent findings by Doblhammer et al. \[[@b3-jpmph-49-2-134]\] who reported a deficit of winter births among dementia cases. They suggested that the association might be due to the thrifty phenotype and the developmental origins of health and disease hypotheses \[[@b2-jpmph-49-2-134]\], or socioeconomic differences in the pro-creational habits, i.e., socioeconomic influences on seasonal conception/birth rates \[[@b3-jpmph-49-2-134]\]. Previous studies that have assessed the association of season of birth and AD have often been based on small, selected cohorts which may impact their generalisability and make them unpowered to detect an association. The largest study to date included 727 AD cases \[[@b11-jpmph-49-2-134]\], while three of the previous studies included less than hundred AD cases \[[@b14-jpmph-49-2-134]-[@b16-jpmph-49-2-134]\]. Similar to ours, majority of the previous studies concluded with null findings \[[@b11-jpmph-49-2-134]-[@b16-jpmph-49-2-134]\]. Thus, the two studies showing a seasonal effect \[[@b9-jpmph-49-2-134],[@b10-jpmph-49-2-134]\] may be chance findings. Latitude/hemisphere is unlikely to explain the heterogeneity as the studies that found an association were conducted in Germany \[[@b3-jpmph-49-2-134]\], UK \[[@b9-jpmph-49-2-134]\], and Canada \[[@b10-jpmph-49-2-134]\] while the null studies have been conducted in UK, US, Germany, Sweden and Australia \[[@b11-jpmph-49-2-134]-[@b16-jpmph-49-2-134]\]. Cohort effect, i.e., association dependent on year or decade of birth as shown for schizophrenia \[[@b8-jpmph-49-2-134]\] does also not explain this heterogeneity.

One of the strengths of our study is the sample size. Thus, the null results are unlikely to be due to lack of power. We were able to identify all community-dwelling persons with clinically verified AD diagnosis. Further, due to the standardised diagnostic criteria, the positive predictive value of AD diagnosis in our study is high \[[@b20-jpmph-49-2-134]\]. Some of the controls may have had undiagnosed AD, but it is unlikely that these undiagnosed cases would be unequally distributed across exposure categories, so this would dilute the estimates of our study towards the null by increasing the uncertainty around the point estimate. However, this would not affect the point estimate which was very close to 1 for all categories. Finland spans from the 60°N to 70°N and thus, the location of birth might matter. These data were not available, but the propensity for intermunicipal migration in Finland is rather low \[[@b19-jpmph-49-2-134]\] and two-thirds of Finnish people live in the county where they were born \[[@b20-jpmph-49-2-134]\]. Thus, especially in this age group, the location, or at least latitude, at the time of AD diagnosis was likely a very close approximation to their birth place. As our study sample was not selected on the basis of age, sex, socioeconomic position or e.g., participation in a certain insurance scheme, the findings should be fairly generalisable. Further, it is unlikely that ethnic background would affect the association between season of birth and AD/dementia. Thus the results should be generalisable also to other ethnic groups.

In conclusion, our nationwide study did not provide strong evidence that season of birth would affect the predisposition to AD. Although these findings do not support the hypothesis that season of birth is related to AD/dementia risk, they do not invalidate the DOHAD hypothesis in late-life cognition. It is possible that season does not adequately capture the early life circumstances, or that other (postnatal) risk factors such as lifestyle or socioeconomic factors overrule the impact of prenatal and perinatal factors.
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###### 

Association between month of birth and Alzheimer's disease

  Month       Cases (n = 70 719)   Controls (n = 282 862)   OR (95%CI)         *p*-value
  ----------- -------------------- ------------------------ ------------------ -----------
  January     6113 (8.6)           24 656 (8.7)             1.00 (reference)   0.09
  February    5488 (7.8)           21 783 (7.7)             1.02 (0.98,1.06)   
  March       6120 (8.7)           24 865 (8.8)             0.99 (0.95,1.03)   
  April       6020 (8.5)           23 710 (8.4)             1.02 (0.98,1.07)   
  May         6203 (8.8)           24 552 (8.7)             1.02 (0.98,1.06)   
  June        6189 (8.8)           24 533 (8.7)             1.02 (0.98,1.06)   
  July        6514 (9.2)           25 260 (8.9)             1.04 (1.00,1.08)   
  August      6026 (8.5)           24 202 (8.6)             1.00 (0.97,1.04)   
  September   5841 (8.3)           23 048 (8.2)             1.02 (0.98,1.06)   
  October     5360 (7.6)           21 714 (7.7)             1.00 (0.96,1.04)   
  November    5211 (7.4)           21 161 (7.5)             0.99 (0.95,1.04)   
  December    5634 (8.0)           23 378 (8.3)             0.97 (0.93,1.01)   

Values are presented as number (%).

OR, odds ratio; CI, confidence interval.

###### 

Association between season of birth and Alzheimer's disease

  Season   Cases (n = 70 719)   Controls (n = 282 862)   OR (95% CI)        *p*-value
  -------- -------------------- ------------------------ ------------------ -----------
  Winter   22 446 (31.7)        90 978 (32.2)            1.00 (reference)   0.13
  Spring   18 343 (25.9)        73 127 (25.9)            1.02 (0.99,1.04)   
  Summer   18 729 (26.5)        73 995 (26.2)            1.03 (1.00,1.05)   
  Autumn   11 201 (15.8)        44 762 (15.8)            1.02 (0.99,1.04)   

Values are presented as number (%).

OR, odds ratio; CI, confidence interval.
